Jason Boer

A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang et al. · Clinical Cancer Research · 2011 · 274 citations

Medicine, Oncology, Pharmacology +16

Species-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications

Sharon Diamond, Jason Boer, Thomas Maduskuie et al. · Drug Metabolism and Disposition · 2010 · 138 citations

Medicine, Pharmacology, Toxicology +15

The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy

Qiang Zhang, Yan Zhang, Sharon Diamond et al. · Drug Metabolism and Disposition · 2014 · 121 citations

Medicine, Pharmacology, Pharmacotherapy +14

Biotransformation: Impact and Application of Metabolism in Drug Discovery

Julia Shanu-Wilson, Liam Evans, Stephen K. Wrigley et al. · ACS Medicinal Chemistry Letters · 2020 · 107 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity

Daniel P. Walker, Michael P. Zawistoski, Molly A. McGlynn et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 88 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13